Popular drugs for diabetes and weight loss could have an unexpected side effect. Glucagon-like peptide 1 (GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked ...
For patients, a new diagnosis of diabetes can be overwhelming. It means not only managing blood sugar but also preventing serious future health complications such as diabetic retinal disease, a ...
Recent findings have shown that routine eye screening could also be used for early detection of underlying heart disease in ...
November is Diabetes-related Eye Disease Awareness Month, and early detection and treatment of diabetes are key to reduce the risk for significant vision loss and blindness, according to Prevent ...
Glucagon-like peptide-1 receptor agonist drugs (commonly referred to as GLP-1 agonists) have become widely prescribed for ...
Headlines warning about “Ozempic blindness” may be frightening to the millions of people taking a GLP-1 drug to treat Type 2 diabetes or for weight loss. It's not an official diagnosis, but an ...
Share on Pinterest New research links GLP-1 medications such as semaglutide and tirzepatide to a doubled risk of potentially blinding eye diseases. Javier Zayas Photography/Getty Images The most ...
Ozempic blindness isn’t a real diagnosis. It’s a nickname used to describe sudden vision loss that may be linked to the weight loss drugs semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results